메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
도현수 (Division of Rheumatology Department of Internal Medicine Yonsei University College of Medicine Seoul Korea) 표정윤 (Division of Rheumatology Department of Internal Medicine Yonsei University College of Medicine Seoul KoreaInstitute for Immunology and Immunological Diseases Yonsei University College of Medicine Seou) 송정식 (Division of Rheumatology Department of Internal Medicine Yonsei University College of Medicine Seoul KoreaInstitute for Immunology and Immunological Diseases Yonsei University College of Medicine Seou) 박용범 (Division of Rheumatology Department of Internal Medicine Yonsei University College of Medicine Seoul KoreaInstitute for Immunology and Immunological Diseases Yonsei University College of Medicine Seou) 이상원 (Division of Rheumatology Department of Internal Medicine Yonsei University College of Medicine Seoul KoreaInstitute for Immunology and Immunological Diseases Yonsei University College of Medicine Seou)
저널정보
대한류마티스학회 대한류마티스학회지 대한류마티스학회지 제30권 제1호
발행연도
2023.1
수록면
45 - 52 (8page)
DOI
10.4078/jrd.22.0033

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: This study investigated the clinical implications of serious infections in patients with antineutrophil cytoplasmic antibody- associated vasculitis (AAV) who received the first cycle of rituximab (RTX) during the first 6 months of follow-up. Methods: The medical records of 36 AAV patients treated with RTX were reviewed. A weekly dose of 375 mg/m2 RTX was administered for 4 weeks to all patients along with glucocorticoids. Serious infections were defined as those requiring hospitalization. All-cause mortality during the first 6 months of follow-up was counted. The follow-up duration was defined as the period from the first RTX infusion to 6 months after the first RTX infusion. Results: The median age was 60.5 years, and 16 patients were male. Seven of 36 patients (19.4%) died and three AAV patients had five cases of serious infection such as enterocolitis, pulmonary aspergillosis, atypical pneumonia, cytomegalovirus pneumonia, and cellulitis. AAV patients with serious infections during the first 6 months of follow-up exhibited a significantly lower cumulative survival rate than those without serious infections (p<0.001). However, we found no independent predictor of serious infections using the Cox hazard model analysis. Conclusion: Serious infection is an important predictor of all-cause mortality in Korean patients with AAV who received their first cycle of RTX but there were no significant variables to predict the occurrence of serious infections at the first RTX. Thus, in cases refractory to other induction therapies, RTX should be strongly considered, despite an increase in mortality rate.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0